UPXI

Value Q1, 25Q2, 25Q3, 25 TTM Total revenue 9.24 M8.05 M4.56 M 26.14 M Gross profit 8.28 M6.71 M4.35 M 22.75 M Operating expenses -60.87 M182.08 M111.14 M 242.25 M Selling/general/admin expenses 10.32 M6.44 M5.48 M 29.6 M Research & development ——— — Operating income 69.16 M-175.36 M-106.79 M -219.5 M Non-Operating Income, Total -2.41 M-3.56 M-2.56 M -8.95 M Interest expense, net of interest capitalized 20.98 K17.77 K15.59 K 48.51 K Non-Operating Income, excl. Interest Expenses -2.72 M-3.62 M-2.57 M -9.57 M Unusual income/expense 292.23 K44.61 K1.13 M 1.7 M Pretax income 66.75 M-178.92 M-109.34 M -228.45 M Equity in earnings ——— — Taxes 000 0 Non-controlling/minority interest ——— — After tax other income/expense ——— — Net income before discontinued operations 66.75 M-178.92 M-109.34 M -228.45 M Discontinued operations ——— — Net income 66.75 M-178.92 M-109.34 M -228.45 M Dilution adjustment ——— — Preferred dividends ——— — Diluted net income available to common stockholders 66.75 M-178.92 M-109.34 M -228.45 M Basic earnings per share (Basic EPS) 1.21-2.94-1.67 0.53 Diluted earnings per share (Diluted EPS) 0.76-2.75-1.67 -2.83 Average basic shares outstanding 55.34 M60.83 M65.51 M — Diluted shares outstanding 88.48 M60.83 M65.51 M — EBITDA 69.33 M-175.18 M-108.43 M -220.68 M EBIT 69.16 M-175.36 M-106.79 M -219.5 M Cost of revenue 956.74 K1.34 M206.37 K 3.39 M Other cost of goods sold 70.4 K160.94 K-231.34 K 330.89 K Depreciation & amortization (cash flow) 175.26 K186.33 K-1.64 M -1.18 M